Monopar Therapeutics Inc.

Q2 2025 13F Holders

Symbol
MNPR
CUSIP
61023L207
Type
Equity
Class
COM NEW
Num filings
45
Total reported value, excl. options
$113 M
Manager Report Date Value ($000) Shares Option Type